Related Experiment Video
Updated: Nov 1, 2025

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
Published on: April 13, 2015
Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly
Andrea Ziblat1, Ximena Lucía Raffo Iraolagoitia1, Sol Yanel Nuñez1
1Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina.
Abstract:
Although natural killer (NK) cells infiltrate clear cell renal cell carcinomas (ccRCC), the most frequent malignancy of the kidney, tumor progression suggests that they become dysfunctional. As ccRCC-driven subversion of NK cell effector functions is usually accompanied by phenotypic changes, analysis of such alterations might lead to the identification of novel biomarkers and/or targets in immuno-oncology. Consequently, we performed a phenotypic analysis of peripheral blood NK cells (PBNK) and tumor-infiltrating NK cells (TINK) from ccRCC patients. Compared to HD, PBNK from ccRCC patients exhibited features of activated cells as shown by CD25, CD69 and CD62L expression. They also displayed increased expression of DNAM-1, CD48, CD45, MHC-I, reduced expression of NKG2D, and higher frequencies of CD85j+ and PD-1+ cells. In addition, compared to PBNK from ccRCC patients, TINK exhibited higher expression of activation markers, tissue residency features and decreased expression of the activating receptors DNAM-1, NKp30, NKp46, NKp80 and CD16, suggesting a more inhibitory phenotype. Analysis of The Cancer Genome Atlas (TCGA) revealed that CD48, CD45, CD85j and PD-1 are significantly overexpressed in ccRCC and that their expression is associated with an NK cell infiltration signature. Calculation of z-scores revealed that their expression on PBNK, alone or combined, distinguished ccRCC patients from HD. Therefore, these molecules emerge as novel potential biomarkers and our results suggest that they might constitute possible targets for immunotherapy in ccRCC patients.
Insights
Natural killer (NK) cells in kidney cancer (ccRCC) show dysfunction. Researchers identified specific cell markers on peripheral blood NK cells that can distinguish ccRCC patients from healthy donors, suggesting new biomarkers and immunotherapy targets.
Area of Science:
- Immunology
- Oncology
- Renal Cell Carcinoma Research
Background:
- Natural killer (NK) cells are crucial immune cells that infiltrate clear cell renal cell carcinomas (ccRCC).
- Despite infiltration, NK cells often become dysfunctional within the tumor microenvironment, hindering anti-tumor immunity.
- Understanding NK cell phenotypic changes in ccRCC is vital for identifying new biomarkers and therapeutic targets.
Purpose of the Study:
- To perform a detailed phenotypic analysis of peripheral blood NK cells (PBNK) and tumor-infiltrating NK cells (TINK) in ccRCC patients.
- To identify potential biomarkers and immunotherapy targets by analyzing NK cell surface marker expression.
- To correlate NK cell marker expression with ccRCC patient status and NK cell infiltration.
Main Methods:
- Phenotypic analysis of PBNK and TINK from ccRCC patients and healthy donors (HD) using flow cytometry.
- Analysis of The Cancer Genome Atlas (TCGA) data to assess gene expression in ccRCC tumors.
- Statistical analysis, including z-score calculations, to identify distinguishing markers.
Main Results:
- PBNK from ccRCC patients showed increased expression of CD25, CD69, CD62L, DNAM-1, CD48, CD45, MHC-I, and PD-1, with reduced NKG2D and increased CD85j+
- TINK exhibited higher activation markers and tissue residency features but decreased expression of activating receptors (DNAM-1, NKp30, NKp46, NKp80, CD16), indicating an inhibitory phenotype.
- TCGA analysis revealed significant overexpression of CD48, CD45, CD85j, and PD-1 in ccRCC, associated with NK cell infiltration signatures. These markers, particularly on PBNK, differentiated ccRCC patients from HD.
Conclusions:
- Specific phenotypic markers on NK cells, including CD48, CD45, CD85j, and PD-1, are altered in ccRCC patients.
- These markers, especially when evaluated on PBNK, show potential as novel biomarkers for distinguishing ccRCC patients from healthy individuals.
- The identified markers represent promising targets for developing novel immunotherapies to enhance anti-tumor responses in ccRCC.
More Related Videos
09:32Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Inhibition of Cdk Activity